Registration - Organization

Innovative Medicines Canada (Medicaments novateurs Canada) / Bettina Hamelin, President

Registration Information

Organization name: Innovative Medicines Canada (Medicaments novateurs Canada)
Senior Officer Name: Bettina Hamelin, President
Senior Officer Change History
Initial registration start date: 2015-09-22
Registration status: Active
Projected end date: No date provided
Registration number: 10310-1774

Associated Lobbying Activity Reports

Total number of Lobbying Activity Reports: 28

Lobbying Activity Reports - last 6 months: 4

Version 55 of 59 (2024-04-08 to 2024-04-08)

Registration versions:

Version 55 of 59 (2024-04-08 to 2024-04-08)

Lobbying Information

Subject Matter of the Lobbying Activities

Details Regarding the Identified Subject Matter

Will any of the lobbyists listed within this registration arrange a meeting between a public office holder and any other individual for the purpose of attempting to influence any of the matters listed below:

Specific Topics of Lobbying Communications	Intended Outcomes	Associated Subject Matters
Advocate for the adoption of innovative payer agreements at the pan-Canadian level that would incorporate real world evidence	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Health
Advocate for workload capacity building and the acceleration of the work of the pan-Canadian Pharmaceutical Alliance which is an intergovernmental collaboration currently chaired by BC	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Health
Budget 2024 preparation and submission discussion.	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Economic Development and Trade, Finances and Budgets, Health
Discussion on the Pharmaceutical Care Management Strategy	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Health
Engage with the BC government to advocate for greater access to innovative medicines and vaccines for British Columbians, supportive policies to attract research and development investment, and greater collaboration to build a stronger life sciences sector and a more sustainable health system.	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	COVID-19, Economic Development and Trade, Finances and Budgets, Government Procurement, Health, Industry
Introductory meeting, update on life sciences strategy, life sciences sector value to BC in health and economic recovery.	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Economic Development and Trade, Finances and Budgets, Health
Introductory meeting – we spoke about IMC and our members value to BC in health and economic recovery.	Development of any legislative proposal by the government of British Columbia, a Provincial entity or a member of the Legislative Assembly Introduction, amendment, passage or defeat of any Bill or resolution in or before the Legislative Assembly Development or enactment of any regulation, including the enactment of a regulation for the purposes of amending or repealing a regulation Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity Awarding, amendment or termination of any contract, grant or financial benefit by or on behalf of the government of British Columbia or a Provincial entity Decision by the Executive Council or a member of the Executive Council to transfer from the Crown for consideration all or part of, or any interest in or asset of, any business, enterprise or institution that provides goods or services to the Crown, a Provincial entity or the public Decision by the Executive Council or a member of the Executive Council to have the private sector instead of the Crown provide goods or services to the government of British Columbia or a Provincial entity	Health
life sciences sector	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Health
PharmaCare budget, pharmaceutical listings and the Pharmaceutical Care Management Strategy	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Health

BC Ministries/Provincial Entities

Children and Family Development
Finance
Fraser Health Authority
Health
Innovate BC
Interior Health Authority
Providence Health Care Society
Provincial Health Services Authority
Simon Fraser University
University of British Columbia
University of Victoria
Vancouver Coastal Health Authority

Organization Details

Senior Officer Name and Position during the Period of this Registration

Bettina Hamelin, President

Organization Contact Information

Innovative Medicines Canada (Medicaments novateurs Canada)

Address:
55 Metcalfe Street
Suite 1220
Ottawa, ON K1P 6L5
Canada

Telephone number: 613-236-0455

Description of Activities

Innovative Medicines Canada represents the innovative pharmaceutical industry in Canada. We help our members discover, develop, and deliver innovative medicines and vaccines. Our membership consists of more than 50 companies, from established organizations to fledgling startups, all of whom are revolutionizing healthcare through the discovery and development of new medicines and vaccines. Guided by a strict Code of Ethical Practices, we work with governments, insurance companies, healthcare professionals and stakeholders to advance the field and enhance the well-being of Canadians. We are committed to being valued partners for the healthcare system in Canada. We aim to achieve these goals by forming effective alliances and supporting policies, improving the regulatory environment, widen access to innovative medicines and protect intellectual property in Canada. We believe in ensuring that Canadians have access to the innovative treatments they need and that our activities are a fundamental part of safeguarding our healthcare system for future generations. Our work allows our members to focus on what matters: delivering better healthcare solutions to Canadians.

Gifts or benefits provided by the organization

Gifts or Benefits Provided to Public Officer Holders
Name	Gift or Benefit Description	Circumstance	Date Promised	Value Promised	Date Given	Value Given
No Records

Contributors to the Lobbying Activity

No person or organization contributed over $1000CDN, within the preceding 12 months, toward the lobbying activity on behalf of the organization that has a direct interest in the outcome of the lobbying activity.

Government Funding in the Last 12 Months

No government funding was requested or received within the preceding 12 months.

Coalition Members Information

Innovative Medicines Canada (Medicaments novateurs Canada) is not a coalition member.

Affiliates with a Direct Interest in the Outcome

Innovative Medicines Canada (Medicaments novateurs Canada) does not have any affiliates that could have a direct interest in the outcome of the lobbying activities

Other Persons or Organizations with Direct Interests

The activities of Innovative Medicines Canada (Medicaments novateurs Canada) are not controlled or directed by another person or organization with a direct interest in the outcome of this undertaking.

Lobbyists Details

Lobbyists Employed by this Organization

Lobbyist

Contributions

Ashley Bergwerff
Subscribes to a Code of Conduct: Yes
Former Public Office Holder in BC: No